by Combat Cancer | Oct 25, 2024 | News
Voided urine cytology (VUC) has been identified as a valuable tool in identifying the risk of non-muscle-invasive bladder cancer (NMIBC) before surgery. In a study published in Urologic Oncology: Seminars and Original Investigations, researchers Gómez del Cañizo and...
by Combat Cancer | Oct 20, 2024 | News
Pancreatic cancer is one of the most challenging and least survivable cancers. Despite advancements in medicine, it remains difficult to diagnose and treat effectively. The new National Pancreatic Cancer Audit (NPaCA) has just released its first quarterly update,...
by Combat Cancer | Oct 12, 2024 | News
A new study led by researchers from Weill Cornell Medicine and the New York Genome Center has provided unprecedented insights into the origins and progression of bladder cancer. Published on 9th October 2024 in Nature, the paper titled “The interplay of...
by Combat Cancer | Oct 4, 2024 | News
Chemotherapy can be tough on patients, but advancements in medical technology are making treatments more effective and less burdensome. One such innovation is a new implantable catheter system designed to facilitate optimal chemotherapy recirculation, ensuring that...
Recent Comments